Skip to content

Atossa Therapeutics, Inc.

ATOS· Nasdaqxbrl foundCIK 1488039

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.94%
Market cap
$19.46M
9.98M shares
Filings
643
$0.00
Q3 2016−95.6% FY15 yoy
-$5.64M
Q3 2026N/M FY25 yoy
-$5.90M
Q3 2026N/M FY25 yoy
-$24.75M
Q3 2026derivedN/M FY25 yoy
-$0.56
Q3 2026N/M FY25 yoy
$20.57M
Q3 2026−41.9% FY25 yoy
$19.46M
—
—
0.9×
-153.06%
—

FY2025 figures · derived

Price

$1.95+136.25%+$1.12past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.76KFY 2015
$632.56K0FY 2011FY 2012FY 2013FY 2014FY 2015
PeriodEndedValueKindSource trail
FY 20152015-12-31$1,758reported
FY 20142014-12-31$40,138 revisedreported
FY 20132013-12-31$632,558reported
FY 20122012-12-31$481,842reported
FY 20112011-12-31$1,500reported

Capital returns

Dividends and buybacks · FY2022 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$0.00$0.00—129.17M sh+3.1%—
FY2023—$1.48M$1.48M—125.30M sh−1.0%—
FY2022—$0.00$0.00—126.62M sh±0.0%—

Pharmaceutical preparations

Atossa Therapeutics, Inc. is the 388th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Atossa Therapeutics, Inc. · CIK 1488039 · Engraved from SEC EDGAR